Business Context and Reporting Period
Company: Chemed Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended June 30, 1996
Business Overview: Chemed operates through four primary segments: National Sanitary Supply, Roto-Rooter, Omnia, and Patient Care. The company also holds significant investments in other entities, including Omnicare Inc. and Exel Ltd.
Key Financial Metrics
| Metric | Six Months Ended June 30, 1996 | Six Months Ended June 30, 1995 |
|---|---|---|
| Total Sales & Service Revenues | $337,932,000 | $347,202,000 |
| Income from Operations | $15,041,000 | $14,547,000 |
| Net Income | $17,885,000 | $11,591,000 |
| Earnings Per Share (Diluted) | $1.82 | $1.17 |
| Operating Cash Flow | $8,979,000 | $5,053,000 |
| Cash and Cash Equivalents (End of Period) | $32,255,000 | $215,000 |
| Total Debt (Current + Long-term) | $114,469,000 | $117,457,000 |
| Unused Lines of Credit | $82,300,000 | N/A |
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased 3% year-over-year to $337.9 million. This was driven by a 27% decline in the Omnia segment (due to a prior retail division sale) and a 7% decline in National Sanitary Supply (due to the loss of a large fast-food customer).
- Segment Growth: Roto-Rooter revenues increased 12% and Patient Care revenues increased 13%, offsetting declines in other segments.
- Profitability Surge: Net income increased 54% to $17.9 million. This growth was primarily driven by a significant increase in "Other income" ($21.5 million vs. $10.4 million in 1995) resulting from gains on the sale of investments in Omnicare and Exel.
- Cash Position: Cash and cash equivalents grew substantially from $215,000 to $32.3 million, fueled by $30.3 million in proceeds from the sale of investments.
- Operating Margins: Roto-Rooter and Patient Care improved operating margins due to cost management and revenue leverage, while Omnia's margin declined due to competitive pricing pressures in the medical supply market.
Outlook, Risks, and Unusual Items
- Investment Gains (Unusual Item): The company realized pretax gains of $17.4 million from the sale of portions of its investments in Omnicare and Exel during the first six months of 1996. These non-operating gains significantly inflated net income.
- Upcoming Liquidity Event: Chemed expects to receive $27 million in cash and stock in Apria Healthcare Group, Inc. following the merger of Apria and Vitas Healthcare Corporation (in which Chemed holds an investment). This transaction is subject to regulatory approval and expected before year-end 1996.
- Acquisition Activity: The company announced a tender offer to acquire the remaining 42% of Roto-Rooter, Inc. for $41.00 per share.
- Liquidity: Management considers capital sources and liquidity satisfactory, citing $82.3 million in unused credit lines.
- Risks: Omnia faces continued pressure from declining pulp paper prices and competitive environments. National Sanitary Supply faces revenue volatility due to large customer concentration.
Investor Verification Checklist
- Sustainability of Earnings: Verify the extent to which net income growth is driven by recurring operations versus one-time investment gains ($10.9 million after-tax gain in 1996 vs. $4.3 million in 1995).
- Customer Concentration: Assess the impact of the lost fast-food customer on National Sanitary Supply's future revenue stability.
- Omnia Segment Turnaround: Monitor Omnia's ability to restore sales levels through acquisitions given the current competitive pricing environment.
- Capital Allocation: Review the terms and funding sources for the pending tender offer to acquire the remaining shares of Roto-Rooter.
- Regulatory Approval: Confirm the status of the Apria/Vitas merger to ensure the anticipated $27 million cash inflow materializes.